Showing results (111-120 of 128) with videos related to
Sort By:
Pageof 13
Journal of Medicinal Chemistry|September 9, 2015
Identification of Substituted Naphthotriazolediones as Novel Tryptophan 2,3-Dioxygenase (TDO) Inhibitors through Structure-Based Virtual ScreeningJian-Sung Wu, Shu-Yu Lin, Fang-Yu Liao, et al.Bioorganic & Medicinal Chemistry|March 6, 2009
Novel trans-2-aryl-cyclopropylamine analogues as potent and selective dipeptidyl peptidase IV inhibitorsTing-Yueh Tsai, Tsu Hsu, Chiung-Tong Chen, et al.Journal of Medicinal Chemistry|February 7, 2023
Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung CancerMu-Chun Li, Mohane Selvaraj Coumar, Shu-Yu Lin, et al.Journal of Medicinal Chemistry|July 10, 2009
Synthesis and evaluation of 3-aroylindoles as anticancer agents: metabolite approachYu-Shan Wu, Mohane Selvaraj Coumar, Jang-Yang Chang, et al.Journal of Medicinal Chemistry|September 28, 2019
Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung CancerShu-Yu Lin, Yung Chang Hsu, Yi-Hui Peng, et al.Pharmacogenomics|July 18, 2013
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactionsHsiang-Wei Kuo, Shu Chih Liu, Hsiao-Hui Tsou, et al.Journal of Medicinal Chemistry|April 11, 2019
Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT MutantsTsung-Sheng Wu, Wen-Hsing Lin, Hui-Jen Tsai, et al.Cell Chemical Biology|July 18, 2024
Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesiaYi-Han Huang, Shu-Yu Lin, Li-Chin Ou, et al.Cancer Science|November 3, 2010
BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activitiesChih-Bo Hu, Ching-Ping Chen, Teng-Kuang Yeh, et al.Journal of Medicinal Chemistry|December 15, 2015
Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor EfficacyShu-Yu Lin, Teng-Kuang Yeh, Ching-Chuan Kuo, et al.Pageof 13